Tag: Rucaparib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Rucaparib

Platinum Investment Management LTD Has Increased Intel (INTC) Position by $36.39 Million; As ...

Added to Collection on: 2019-06-08 20:45:00

Tags for this article:

Intel
NASDAQ
Intel Corp.
Clovis Oncology
Rucaparib
Platinum Investment Management Ltd
Companies
S&P 500 INDEX - CBOE
Chemical compounds
Organic compounds

Click the tags to see associated articles and topics

View Article Details
As Clovis Oncology (Put) (CLVS) Market Value Declined, Holder Css Upped Its Holding; Microsoft ...

Added to Collection on: 2019-06-08 23:46:49

Tags for this article:

Economy
NASDAQ
Short
MSFT
Microsoft
Microsoft Corp
Clovis Oncology
Rucaparib
Benzazepines
Indoles
Lactams
Companies
S&P 500 INDEX - CBOE
Organic compounds
Ecuador Sucre

Click the tags to see associated articles and topics

View Article Details
Clovis Oncology (NASDAQ:CLVS) Director Buys $48762.00 in Stock

Added to Collection on: 2019-09-09 08:56:15

Tags for this article:

Money
Finance
Economy
NASDAQ
Stock
Clovis Oncology
Rucaparib
Clovis, New Mexico
Benzazepines
Indoles
Lactams
Clovis Oncology Inc.
Price–earnings ratio

Click the tags to see associated articles and topics

View Article Details
Insider Buying: Clovis Oncology (NASDAQ:CLVS) Insider Purchases $279500.00 in Stock

Added to Collection on: 2019-09-11 07:37:30

Tags for this article:

Stock
Clovis Oncology
Rucaparib
Clovis, New Mexico
Benzazepines
Indoles
Lactams
Chemical compounds
Organic compounds

Click the tags to see associated articles and topics

View Article Details
Clovis Oncology (NASDAQ:CLVS) Insider Patrick J. Mahaffy Buys 50000 Shares of Stock

Added to Collection on: 2019-09-10 22:48:45

Tags for this article:

Finance
Stock market
Stock
Clovis Oncology
Rucaparib
Clovis, New Mexico
Benzazepines
Indoles
Lactams
Clovis Oncology Inc.
Price–earnings ratio
Chemical compounds
Organic compounds

Click the tags to see associated articles and topics

View Article Details
Here's Why Clovis Oncology Rose as Much as 25.6% Today

Added to Collection on: 2020-01-15 01:48:45

Tags for this article:

Organic compounds
Health care
Health sciences
Lactams
Orphan drugs
PARP inhibitors
Indoles
Rucaparib
Clovis Oncology
Olaparib
Breakthrough therapy
Priority review

Click the tags to see associated articles and topics

View Article Details
Global Ovarian Cancer Drug Market Is Expected To Gain Market Growth In The Forecast Period Of ...

Added to Collection on: 2021-01-08 15:22:30

Tags for this article:

Drugs
Health
Clinical medicine
Orphan drugs
PARP inhibitors
Oncology
Lactams
Cancer treatments
Rucaparib
Bevacizumab
Ovarian cancer
Olaparib

Click the tags to see associated articles and topics

View Article Details
A Phase II Study of Rucaparib and Nivolumab Immunotherapy in People with Advanced ...

Added to Collection on: 2021-01-24 19:52:30

Tags for this article:

Drugs
Clinical medicine
Medicine
Cancer treatments
Orphan drugs
Bristol-Myers Squibb
Antineoplastic drugs
Breakthrough therapy
Rucaparib
Nivolumab
Cancer
Ruth Plummer

Click the tags to see associated articles and topics

View Article Details
Global Ovarian Cancer Drug Market Industry Outlook 2021-2026||F. Hoffmann-La Roche Ltd, Pfizer ...

Added to Collection on: 2021-01-25 16:42:51

Tags for this article:

Drugs
Health
Clinical medicine
Orphan drugs
PARP inhibitors
Oncology
Lactams
Cancer treatments
Rucaparib
Bevacizumab
Ovarian cancer
Niraparib

Click the tags to see associated articles and topics

View Article Details
Poly Adenosine Diphosphate Ribose Polymerase Market Outlook, Key Financials, Segmental ...

Added to Collection on: 2021-04-09 15:11:15

Tags for this article:

PARP inhibitors
Chemical compounds
Organic compounds
Drugs
Orphan drugs
Lactams
Rucaparib
Olaparib
Poly (ADP-ribose) polymerase
Talazoparib
Tesaro
PARP
Adenosine

Click the tags to see associated articles and topics

View Article Details
Book a Demo